Women on Medicare who get subsidies to help defray the cost of drugs may be less likely to stop taking hormone therapy for breast cancer than those who don't get financial assistance, a U.S. study suggests.
Researchers analyzed data on about 25,000 women who had breast cancer surgery and at least one prescription for pills to curb production of the hormone estrogen - which can fuel tumor growth - or pills to stop estrogen from attaching to cancer cells.
